Connect with us

Cannabis News

California Senate Passes Bill To Delay Marijuana Tax Hike That Already Cleared Assembly In Earlier Form

Published

on

The California Senate has accepted an invoice for the assembly Place the tax hike about this new pause in marijuana products.

The Senate’s pouring committee cleaned the Commission for a week after Matt Haney (d) cleaned the legislation from the Assembly, the whole chamber passed on Wednesday.

Because it was changed, the measure must return to the meeting before sending the governor’s table.

If it is suspended in law, the invoice would interrupt the tax rise for five years. Legislators have until September 12 before the end of the session, and the governor will take measures to its table until October 12.

Christopher Cabaldon (D) said the voting of the Senate that the legalization of the California voters had several goals, including “extinguishing the ilient market” and “environmental social and educational programs” with income income.

“This deal is fraying, because the market collapses,” he said. “Today, California’s legal businesses catch up to 40 percent of the cannabis market. There are six seventy of illegal market, consumer or non-environmental protection.”

“California is losing other states,” Cabaldon said. “Michigan, Oregon and others have much more income and many better work is being done to stop illegal sales. And so there is no tax to rise to 25 percent.”

Jerry McNerney (d) Husbands added “We want to control and reduce the illegal market”.

“The growth of taxes will be the opposite effect,” he said. “People will lead to the illegal black market in cannabis, it’s a bad result.”

A correction taken in the stops of the Senate panel, so the effective date would be in October than immediately. The tax hike ride herself in the last month.

In June, the tax rate of the cannabis rose by 15 percent from July 1, and the advocates would change the budget legislation that would reflect the standalone bill in Hanyy. That was not fruit.

Haney’s measurements passage the budget bill gov. The Gavin Newsom (d) support had a tax freezing tax on the trailer. Assembly speaker Robert Rivas (D) also protected the delay, but Mike McGuire (d) Senate President has blocked From the budget legislation.

Under the Bill of Haney, What advanced through the assembly in JuneThe delayed implementation would not be in force until October. The advocates wanted to see recently, they wanted to see what has been included in the legislation in the legislation, which would affect it.

Before you submission to the Senate Endowing Tax, so until two years, the regulators would adapt the tax rate “, in accordance with non-uninterestaneous tools, it is not exceeded by 19 per cent,” according to a summary. “

The appropriate committee, however, would be to summarize the period of 15% of the tax rate and request the report, “according to the chair. It is not clear what the new timeline would be, however, the revised bill text is not yet available.

Haney’s proposal therefore, therefore, the California tax rate (CDTFA), can adjust the cannabis or cannabis tax rate “, the amount of income that will generate the amount of income by departmental estimators. Fiscal year” text He says.

The department should calculate the amount of income that would meet in the previous year in the previous year “and” calculate this amount by projecting tools based on the work that would meet in the previous calendar work in the previous year.

“The exact goal of the reduction in the tax rate of Kannabis is to provide immediate tax relief to the cannabis industry,” said the measurements. “The effectiveness of this goal can be measured according to the legislature, for the income income of cannabis tax revenue, allowed to reduce the tax rate of cannabis.”

CDTFA, on December 1, 2026, also promises California “Send to the Report to Legislature … CANNABISA Tax revenue income income amounts or loss amounts to reduce the tax rate permitted by this action.”


Marijuana is a moment Monitoring of hundreds of cannabis, psychedelic and drug policy invoices This year’s state legislatures and congresses. Patreon supporters At least $ 25 / monthly enter our interactive maps, graphs and listening to the listening calendar, so they do not lose development.


Learn more about us Marihuana Bill Tracker and become Assistant Patreon to get access.

The Senate’s Endowing Committee last week, also passed by unanimously legislation Kalamu-derived cannabinoid products to integrate the use of medical and adults in the marijuana program to ban cannabinoids derived synthetically. The tables “to delete tax provisions, reviewing and modifying specifications, to review and change the conditions and prohibitions on cannabinoids derived from hemp and hemp,” according to the Chair of the Commission.

He accepted the panel measure To change the law of State Cannabis, cannabis microbusinesses, licensing products directly to patients directly with corrections.

Meanwhile, California officials invite research proposals in the second round of a program Better educate the public on the state marijuana law And politicians help make informed decisions on the subject.

In June, the Governor’s Business and Economic Development Office (Go-Biz) An announced receivers of more than $ 52 million in Community reinvestment support He also financed the non-profit and local health department, Marijuana tax tickets.

This marked Cannabis’s seventh round of Construction Community Conversation (CalCRG) Under the state program.

Legitiation in California has created a number of new grant programs to address the consequences of marijuana prohibition and try to feed the strong and well regulated legal industry.

The Supreme Court of California distinguished the victory for the state marijuana program In June, recovering a smaller quantity judgment, in a case, in a case, he suggested the federal ban, could be used locally to weaken the cannabis market.

The Court of the Supreme Court also arrived in California officials a State Marijuana’s current status and future report-En independent analysts contracted by regulators concluded the Federal Prohibition of Canavies, a federal ban that prevents global trade.

The governor signed an invoice in 2022 Invented to enter the commercial agreements of power of power With other legal states, but this power was on a federal orientation or such an activity was in the evaluation of the State lawyer.

Meanwhile, the California Senate Committee was recently advancing a Bipartisan invoice Psilocybin created a pilot program to military veterans and first answers first.

Marijuana is possible with the help of readers. If you are based on journalism to defend cannabis, consider the commitment to Patreon every month.

Become patreon guard!

(Tagstotranslate) highlighted

Continue Reading

Cannabis News

Greenhouses and more at Fruit Logistica Berlin

Published

on

By











New varieties, new concepts, new packaging, new products, new faces – there was a lot to do in Berlin last week. And, new travel schedules too: due to the black ice, many visitors traveling by plane had to extend their stay or find an alternative mode of transport – or both.

Click here for the photo report.

© Arlette Sijmonsma | MMJDaily.com

Fortunately, our bus drivers got us home safely to the Netherlands, and we were able to take all the photos of the greenhouse suppliers, growers and other related parties, so take a seat and enjoy our Fruit Logistica photo report!

There will be more updates this week, as well as extensive reports from our international Freshplaza colleagues, focused on the fresh produce industry.

Click here for the photo report.










Continue Reading

Cannabis News

Alaska Government Task Force Recommends Legalizing Psychedelic Therapy Upon FDA Approval

Published

on

By

An Alaska psychedelic task force is recommending that the state move forward with plans to provide regulated access to psychedelics if the federal Food and Drug Administration (FDA) allows medical use of substances such as psilocybin and MDMA.

According to a law approved in 2024, after working for about a year studying the issue, Alaska Legislative Task Force on Psychedelic Drug Regulation released its findings and recommendations on Thursday.

“Alaska has one of the nation’s highest rates of domestic violence survivors and combat veterans suffering from PTSD, and many Alaskans continue to struggle with traditional treatments,” Sen. Forrest Dunbar (D), the task force’s leader, said in a press release.

“Our approach to these new medical therapies must be properly and independently evaluated so that if the legislature were to make policy changes, we will do so with empirical data in a properly controlled environment,” the senator said.

The panel’s report lists a number of findings based on a review of the scientific literature and expert testimony. This includes findings that some psychedelics do indeed have “potential therapeutic uses” and that “there is a particular focus on the use of these therapies for veterans, survivors of assault and interpersonal violence, and others with post-traumatic stress disorder (PTSD).

Members emphasized the importance of delivering psychedelic therapies in partnership with “multiple types of providers” to provide comprehensive treatment, rather than leaving it up to the patient.

Among its recommendations, the task force said, “If psychedelic medical therapies are approved by the FDA, the state should take steps to allow them to be used in Alaska, rather than ban their use.”

Alaska regulators should also identify clinical task forces, “whose role is to regularly review up-to-date studies and the evidence base to make recommendations, and rely on those entities to provide ongoing guidance on the use of these therapies,” he said.

“As much as possible, reserve the use of state statute for broad enabling language and essential components of a regulatory structure, and leave most regulatory decisions to the appropriate boards and agencies,” another recommendation reads. “Regulations still require a robust public process to be approved, but they are more predictable and can be updated or changed more easily than statutory amendments that require legislative action.”

“The appropriate parameters for the use of these therapies are likely to change over time as the evidence base matures and FDA approval may be granted for multiple therapies,” he said.

If the FDA continues to approve any psychedelics for medical use, the panel said the Alaska State Board of Medicine should update its guidelines for prescribing controlled substances to include new therapies.

Additionally, if the FDA approves psychedelic drugs and the Drug Enforcement Administration (DEA) federally reschedules substances such as psilocybin, Alaska “should fully reflect federal programming and Risk Evaluation and Mitigation Strategies (REMS), without adding duplicative or conflicting state regulations, and follow the rules for determining whether a DEA license is required.” the report he says

“This approach respects federal science and facilitates access for patients and providers,” he continues.

Additionally, as lawmakers and regulators await a federal decision to advance psychedelic therapies, states should consider legislation to “incorporate the recommendations made in this report to encourage statewide implementation action.”

“Legislation on triggers would require addressing various process and regulatory issues, such as the role and involvement of professional licensing boards, state agencies, and the Controlled Substances Advisory Committee,” the task force said.

The report also says that psychedelic reform should include military veterans’ access to FDA-approved therapies, which could involve working with the US Department of Veterans Affairs (VA) to identify opportunities to participate in clinical trials and pilot programs using new drugs.

“The grant should be considered to ensure active efforts by the American Medical Association (AMA) and the Centers for Medicare and Medicaid Services (CMS) to develop billing codes that will promote sufficient reimbursement for the provision of psychedelic therapy, which are essential to ensure patient access post-FDA approval,” the panel said.

Rep. Justin Ruffridge (R), who also serves as co-chair of the psychedelic panel, said the task force “focused on preparing Alaska for potential federal approval of psychedelic therapies.”

“These recommendations came from months of collaboration and work by medical professionals, advocates and legislators who focused on patient safety, evidence-based care and access, especially for those who have not seen progress through traditional treatments,” he said.

So far two other states have facilitated fully functioning psychedelic programs. Oregon voters legalized the therapeutic psilocybin in 2020and Colorado’s program was approved at the ballot box in 2022, with the state’s governor signing the legislation a year later to create the regulatory framework for the program

Meanwhile, a campaign in Alaska announced in December that it did not get enough signaturesAn initiative to legalize some psychedelics like psilocybin and DMT on the 2026 state ballot.– but the activists have emphasized that “the work is far from over” as they focus on putting the reform measure before the voters in 2028.

“While we won’t be on the ballot in 2026, we’re still on track for 2028, and with the determination, focus and support of our community, we’ll continue to move forward,” Natural Medicine Alaska said in December. “This movement is gaining momentum every day. In fact, 65 percent of Alaskans support this initiative, and that number continues to grow.”

A pre-campaign policy outline explained that the proposal is “under construction”. The Natural Medicine Health Act of 2022 passed by Colorado votersunder last year facilitators administered the state’s first legal dose of psilocybin.

A 2024 poll found that nearly half (49.4 percent) of Alaskan adults would support a ballot measure more broadly. remove criminal penalties for the use of substances such as psilocybin mushrooms.

That support rose significantly—to nearly two-thirds (65 percent)—when participants were told that Alaska has high rates of mental illness that could be treated with psychedelics.

Photo elements courtesy of the user carlosemmaskype and Apollo.

Marihuana Moment is made possible with the help of readers. If you rely on our pro-cannabis journalism to stay informed, consider a monthly Patreon pledge.

Continue Reading

Cannabis News

Anti legalization group fails to collect signatures to roll back laws

Published

on

By











A Maine campaign seeking to significantly roll back the state’s marijuana law failed to submit signatures this week for the November 2026 ballot, meaning anti-cannabis activists will have to move to 2027 if they hope to get the issue before voters.

Amid criticism from reform advocates, industry players and some lawmakers for allegedly deceptive signature-gathering tactics, Mainers for a Safe and Healthy Future apparently couldn’t make the cut by the Feb. 2 deadline.

“Cannabis orders were not returned yesterday,” Assistant Secretary of State for Communications Jana Spaulding told Cannabis Business Times on Tuesday. In Maine, that doesn’t mean the campaign has to start from scratch, though, because they can still put the proposition on next year’s ballot. A Republican Maine lawmaker and marijuana industry advocates raised the alarm last month that prohibitionist campaigners were using deceptive petitions to get voters to sign the petition.

A video shared by Rep. David Boyer (R) appeared to feature an image and audio recording of a person gathering signatures for the ballot measure, in which he grossly misrepresented what the cannabis proposal would accomplish, saying its main goal was to ensure the product’s safety through improved testing.

Read more at Marijuana Moment










Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media